发明名称 Adenosine receptor agonists and antagonists to modulate T cell responses
摘要 Described are uses of A2a adenosine receptor antagonists and agonists to provide long term modulation of immune responses. A2a receptor antagonists in particular are provided to enhance immune responses by reducing T-cell mediated tolerance to antigenic stimuli and agonists are provided to enhance effectiveness of immunosuppressive agents. The application provides methods of treatment and prevention based on the long term effects of the compounds on T cell responses.
申请公布号 US9585957(B2) 申请公布日期 2017.03.07
申请号 US200812676741 申请日期 2008.09.08
申请人 THE JOHNS HOPKINS UNIVERSITY 发明人 Powell Jonathan D;Drake Charles George;Zarek Paul
分类号 A61K39/00;A61P37/00;A61P35/00;A61K45/06;A61K39/395 主分类号 A61K39/00
代理机构 Johns Hopkins Technology Transfer 代理人 Johns Hopkins Technology Transfer
主权项 1. A method of treating or preventing abnormal cell proliferation in a host, comprising administering to said host an A2a receptor antagonist in combination or alternation with a mammalian cell based vaccine, wherein the mammalian cell is genetically modified.
地址 Baltimore MD US
您可能感兴趣的专利